Cargando…
Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662553/ https://www.ncbi.nlm.nih.gov/pubmed/37985998 http://dx.doi.org/10.1186/s12951-023-02140-6 |
_version_ | 1785148561176920064 |
---|---|
author | Shi, Chen Jian, Chen Wang, Lulu Gao, Chen Yang, Ting Fu, Zhiwen Wu, Tingting |
author_facet | Shi, Chen Jian, Chen Wang, Lulu Gao, Chen Yang, Ting Fu, Zhiwen Wu, Tingting |
author_sort | Shi, Chen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10662553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106625532023-11-21 Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy Shi, Chen Jian, Chen Wang, Lulu Gao, Chen Yang, Ting Fu, Zhiwen Wu, Tingting J Nanobiotechnology Correction BioMed Central 2023-11-21 /pmc/articles/PMC10662553/ /pubmed/37985998 http://dx.doi.org/10.1186/s12951-023-02140-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Shi, Chen Jian, Chen Wang, Lulu Gao, Chen Yang, Ting Fu, Zhiwen Wu, Tingting Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy |
title | Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy |
title_full | Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy |
title_fullStr | Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy |
title_full_unstemmed | Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy |
title_short | Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy |
title_sort | correction: dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662553/ https://www.ncbi.nlm.nih.gov/pubmed/37985998 http://dx.doi.org/10.1186/s12951-023-02140-6 |
work_keys_str_mv | AT shichen correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy AT jianchen correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy AT wanglulu correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy AT gaochen correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy AT yangting correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy AT fuzhiwen correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy AT wutingting correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy |